TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27799456

Group type: EXPERIMENTAL
Intervention: Stroke education intervention (lecture, educational flyers, magnetic posters)
Number of subjects: 764

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 764
Study: 26414435

Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 38

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 38
Study: 24525257

Group type: EXPERIMENTAL
Intervention: 3‐epi‐25‐OH‐D₃
Number of subjects: 155
Study: 22748484

Group type: EXPERIMENTAL
Intervention: COPD present
Number of subjects: 4133

Group type: COMPARATOR
Intervention: No COPD
Number of subjects: 4133
Study: 19574176

Group type: EXPERIMENTAL
Intervention: Calcium (1,000 mg) and Vitamin D (400 IU)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Calcium (1,000 mg) and Vitamin D (400 IU) plus Metformin (1,500 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Metformin (1,500 mg)
Number of subjects: 60
Study: 17291216

Group type: EXPERIMENTAL
Intervention: MMF stop group (reduced and then stopped MMF dose)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control group (continued tacrolimus/MMF/steroids triple regimen)
Number of subjects: 152
Study: 16236868

Group type: EXPERIMENTAL
Intervention: Heated humidification at CPAP initiation
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (no heated humidification unless upper airway symptoms present)
Number of subjects: 98
Study: 12466028

Group type: EXPERIMENTAL
Intervention: S-adenosyl-L-methionine (SAMe) 400 mg/d intramuscularly
Number of subjects: 293

Group type: COMPARATOR
Intervention: Imipramine (IMI) 150 mg/d orally
Number of subjects: 293
Study: 10201428

Group type: COMPARATOR
Intervention: 1H‐MRS with PRESS sequence (TE/TR, 135 ms/2000 ms)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 1H‐MRS with STEAM sequence (TE/TM/TR, 20 ms/13.7 ms/2000 ms)
Number of subjects: 12
Study: 8567842

Group type: COMPARATOR
Intervention: Wash and swim-up method (2 wash cycles in EBSS, 60 min swim-up)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Two layer Percoll gradient (1 ml semen layered on 36 and 81% Percoll gradient)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Underlay method (2 wash cycles, resuspended in remaining medium, swim-up for 1 h)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: SpermPrep II method (1 ml semen run through SpermPrep II column)
Number of subjects: 15
Study: 2266340

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Both Hydrochlorothiazide and Metoprolol
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 65
Study: 7306434

Group type: EXPERIMENTAL
Intervention: Clenbuterol (40, 60 and 80 micrograms)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Terbutaline (2.5 and 5 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Clenbuterol and Terbutaline
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Clenbuterol (larger doses)
Number of subjects: 13
Study: 30620134

Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted prompted voiding (USAPV)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional prompted voiding (CPV)
Number of subjects: 80
Study: 25534063

Group type: EXPERIMENTAL
Intervention: Total frontal reconstruction and transferring of onlay bone grafts to the recessive superior orbital rim (n = 7)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Total frontal reconstruction and unilateral fronto‐orbital advancement (n = 5)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intergroup comparison of both surgical techniques
Number of subjects: 12
Study: 24645550

Group type: EXPERIMENTAL
Intervention: Pharmacoinvasive myocardial reperfusion with prehospital thrombolysis
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Prehospital thrombolysis before coronary angioplasty
Number of subjects: 289
Study: 21120661

Group type: EXPERIMENTAL
Intervention: 1% lidocaine + 0.000625% adrenalin
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: 0.375% ropivacaine
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine
Number of subjects: 143

Group type: COMPARATOR
Intervention: 0.9% sodium chloride (control)
Number of subjects: 143
Study: 19250100

Group type: EXPERIMENTAL
Intervention: Dynamic atrial overdrive pacing (algorithm ON-OFF)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dynamic atrial overdrive pacing (algorithm OFF-ON)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study: 17908743

Group type: EXPERIMENTAL
Intervention: America on the Move group (n = 100)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Self-monitor group (n = 92)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Both groups (America on the Move and self-monitor)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Parents in both groups
Number of subjects: 192
Study: 15491244

Group type: EXPERIMENTAL
Intervention: Citalopram plus mirtazapine (15-30 mg/day)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Citalopram plus placebo
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Citalopram plus mirtazapine
Number of subjects: 49
Study: 11011813

Group type: EXPERIMENTAL
Intervention: CHOP Infant Coma Scale (IFS)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Glasgow Coma Scale (GCS)
Number of subjects: 85

Group type: COMPARATOR
Intervention: GCS
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: IFS
Number of subjects: 85
Study: 9157451

Group type: EXPERIMENTAL
Intervention: Physiotherapy with RC-Cornet
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Physiotherapy with VRP1 Desitin
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (daily 40 mg prednisolon i.v., 2 x theophylline i.v., 3 x inhalation of beta 2+ parasympathicolytic)
Number of subjects: 90
Study: 1727093

Group type: COMPARATOR
Intervention: Pyrimethamine plus sulfadiazine (PS)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Pyrimethamine plus clindamycin (PC)
Number of subjects: 59
Study: 6238136

Group type: EXPERIMENTAL
Intervention: Fluorouracil plus streptozocin (5‐FU plus STZ)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 172

Group type: COMPARATOR
Intervention: Doxorubicin (after crossover from 5‐FU plus STZ)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Fluorouracil plus streptozocin (5‐FU plus STZ) (after crossover from doxorubicin)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 172
Study: 31737676

Group type: EXPERIMENTAL
Intervention: Vegetable powder-supplemented chapatti (VPSC)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bean powder-supplemented chapatti (BPSC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: All-purpose wheat flour chapatti (APFC)
Number of subjects: 24
Study: 29024499

Group type: EXPERIMENTAL
Intervention: Men's Club intervention (5-hour interactive educational intervention + weekly text message reminders for 6 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (educational pamphlets only)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Men's Club intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 26950082

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 63
Study: 24612659

Group type: EXPERIMENTAL
Intervention: Combination therapy with solifenacin 5 mg and mirabegron (various doses)
Number of subjects: 1306

Group type: COMPARATOR
Intervention: Solifenacin 5 mg monotherapy
Number of subjects: 1306

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1306
Study: 23007324

Group type: EXPERIMENTAL
Intervention: AR-GG27® cream (sorbityl furfural palmitate)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 20398559

Group type: EXPERIMENTAL
Intervention: Drug intervention group (hydrochlorothiazide, nitrendipine, and captopril)
Number of subjects: 4984

Group type: COMPARATOR
Intervention: Control group (health education)
Number of subjects: 4984

Group type: EXPERIMENTAL
Intervention: Drug intervention group
Number of subjects: 4984

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 4984
Study: 19011219

Group type: EXPERIMENTAL
Intervention: Brief health risk appraisal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 0
Study: 15962570

Group type: EXPERIMENTAL
Intervention: Multivariate statistical analysis of body measurements
Number of subjects: 0
Study: 12691602

Group type: EXPERIMENTAL
Intervention: Dietary sodium restriction (<80 mmol/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 15
Study: 10447620

Group type: EXPERIMENTAL
Intervention: Patient-Controlled Analgesia (PCA) with piritramid via PCA pump
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional Pain Therapy (CPT) with tramadol (oral or intramuscularly) or piritramid intravenously
Number of subjects: 38
Study: 8665039

Group type: EXPERIMENTAL
Intervention: GER+IMT
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: GER
Number of subjects: 25

Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 25
Study: 1687324

Group type: EXPERIMENTAL
Intervention: 0.3% chlorpheniramine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 0.3% dexbrompheniramine
Number of subjects: 13

Group type: COMPARATOR
Intervention: 0.3% pheniramine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 0.4% pheniramine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 0.5% pheniramine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 0.1% chlorpheniramine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 0.2% chlorpheniramine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 0.2% pyrilamine
Number of subjects: 13
Study: 656248

Group type: EXPERIMENTAL
Intervention: Spontaneous breathing
Number of subjects: 16

Group type: COMPARATOR
Intervention: Controlled ventilation with 1% chloroform
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study: 31153095

Group type: EXPERIMENTAL
Intervention: Appeals contesting resistant responses
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Attribution-based manipulation
Number of subjects: 101
Study: 28953632

Group type: EXPERIMENTAL
Intervention: Verum PENS
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham PENS
Number of subjects: 62
Study: 25611898

Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopy
Number of subjects: 88

Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 88
Study: 23631443

Group type: EXPERIMENTAL
Intervention: Remogliflozin etabonate (RE)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Coadministration of metformin and RE
Number of subjects: 13
Study: 21823379

Group type: EXPERIMENTAL
Intervention: SLIPA (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Endotracheal tube group (n = 20)
Number of subjects: 40
Study: 19205723

Group type: EXPERIMENTAL
Intervention: Aquatic exercise (AE; n = 15)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Elastic bands (EB; n = 21)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (n = 10)
Number of subjects: 46
Study: 17284576

Group type: EXPERIMENTAL
Intervention: Stavudine, 30-40 mg, twice a day for 1 month
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo for 1 month
Number of subjects: 16
Study: 15945304

Group type: EXPERIMENTAL
Intervention: Unsplinted implants
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Splinted implants
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Splinted bar-retained method
Number of subjects: 18

Group type: COMPARATOR
Intervention: Unsplinted prosthodontic method
Number of subjects: 18
Study: 12823645

Group type: EXPERIMENTAL
Intervention: Raloxifene 150 mg day‐1
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogen (CEE) 0.625 mg day‐1
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 10195186

Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation administered after learning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 8585003

Group type: EXPERIMENTAL
Intervention: 200 IU antiXa/kg of Dalteparin (Fragmin) injected at 8 p.m.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 200 IU antiXa/kg of Dalteparin (Fragmin) injected at 8 a.m.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control cycle without injection
Number of subjects: 10
Study: 2146058

Group type: EXPERIMENTAL
Intervention: ritanserin
Number of subjects: 8

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 8
Study: 304984

Group type: EXPERIMENTAL
Intervention: 500 ml of dextran 60 intraoperatively (group A)
Number of subjects: 91

Group type: COMPARATOR
Intervention: 100 ml dextran 60 on days 1 to 5 after operation (group B)
Number of subjects: 91
Study: 31668468

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 286

Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 286
Study: 29813176

Group type: EXPERIMENTAL
Intervention: Female drivers who frequently use phones for texting/answering calls; less favorable attitudes towards safety; highly disinhibited individuals.
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: More years with a valid driving license; self-efficacy toward self-regulation in demanding traffic conditions; police enforcement; texting tasks; demanding traffic conditions.
Number of subjects: 447
Study: 27803024

Group type: EXPERIMENTAL
Intervention: Flex 11
Number of subjects: 20

Group type: COMPARATOR
Intervention: SBAR
Number of subjects: 20
Study: 24561771

Group type: EXPERIMENTAL
Intervention: 'Benifuuki' green tea containing O‐methylated EGCG
Number of subjects: 51

Group type: COMPARATOR
Intervention: 'Yabukita' green tea (placebo)
Number of subjects: 51
Study: 22555112

Group type: EXPERIMENTAL
Intervention: Ranibizumab monthly treatment
Number of subjects: 1107

Group type: EXPERIMENTAL
Intervention: Bevacizumab monthly treatment
Number of subjects: 1107

Group type: EXPERIMENTAL
Intervention: Monthly treatment
Number of subjects: 1107

Group type: EXPERIMENTAL
Intervention: As-needed treatment
Number of subjects: 1107

Group type: EXPERIMENTAL
Intervention: Switching from monthly to as-needed treatment
Number of subjects: 1107

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 1107

Group type: COMPARATOR
Intervention: Ranibizumab
Number of subjects: 1107
Study: 20395648

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18547128

Group type: COMPARATOR
Intervention: IR methylphenidate (Rubifen) 52.1 mg (SD = 13.8 mg) three times daily for 3 months
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: OROS methylphenidate (Concerta) 57.9 mg (SD = 16.5 mg) once daily after switch
Number of subjects: 70
Study: 16177676

Group type: EXPERIMENTAL
Intervention: Carvedilol treatment (Group I, n=32)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard therapy (Group II, n=27)
Number of subjects: 59
Study: 11901392

Group type: EXPERIMENTAL
Intervention: Cortisone injection into the tendon sheath
Number of subjects: 18

Group type: COMPARATOR
Intervention: Thumb spica splints
Number of subjects: 18
Study: 10413387

Group type: EXPERIMENTAL
Intervention: Self-management program for chronic disease (6 months duration)
Number of subjects: 952

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 952
Study: 7768585

Group type: EXPERIMENTAL
Intervention: Losartan potassium 10 mg
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Losartan potassium 25 mg
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Losartan potassium 50 mg
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Losartan potassium 100 mg
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Losartan potassium 150 mg
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Enalapril maleate 20 mg
Number of subjects: 576

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study: 2186523

Group type: EXPERIMENTAL
Intervention: D/C group (CsA discontinued, maintained on Aza and prednisone)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: TD group (Aza added to continued low-dose CsA and prednisone)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: D/C group
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: TD group
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: TD regimen
Number of subjects: 92
Study: 508705

Group type: EXPERIMENTAL
Intervention: Protein intake at adequate energy intake (418 kJ/kg body‐weight)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Protein intake at decreased energy intake (334 kJ/kg body‐weight)
Number of subjects: 4
Study: 31323175

Group type: EXPERIMENTAL
Intervention: Anatomic lead placement (AP)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Paresthesia-mapped lead placement (PM)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 270
Study: 31141954

Group type: EXPERIMENTAL
Intervention: Moderately high-protein (MHP) diet
Number of subjects: 305

Group type: COMPARATOR
Intervention: Low-fat (LF) diet
Number of subjects: 305
Study: 27903841

Group type: EXPERIMENTAL
Intervention: Exercise Program (EP)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (CT)
Number of subjects: 6
Study: 26478867

Group type: EXPERIMENTAL
Intervention: Pregabalin (n = 10)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (n = 9)
Number of subjects: 39
Study: 23589814

Group type: EXPERIMENTAL
Intervention: Live music interventions (lullaby and rhythm)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Rhythm sound interventions
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Entrained breath sounds
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Parent-preferred lullabies
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 272
Study: 21323289

Group type: EXPERIMENTAL
Intervention: Ropivacaine 24 mg plus morphine 8 mg (group R+M)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Normal saline (group N/S)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Ropivacaine 40 mg (group R)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Ropivacaine 36 mg plus ketoprofen 100 mg (group R+K)
Number of subjects: 156
Study: 18954999

Group type: EXPERIMENTAL
Intervention: Hydroxyurea therapy
Number of subjects: 77
Study: 17096305

Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) intervention by specially trained primary care physicians
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) intervention
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Subgroup of patients with marked preference for SDM
Number of subjects: 84
Study: 15273003

Group type: EXPERIMENTAL
Intervention: Group condition with fellow ingroup members present
Number of subjects: 0
Study: 10740573

Group type: EXPERIMENTAL
Intervention: Larva therapy (LT)
Number of subjects: 70
Study: 9193008

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enalapril and ASA interaction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patients taking ASA
Number of subjects: 0
Study: 1441873

Group type: EXPERIMENTAL
Intervention: Epidural morphine 5 mg (Group 2)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (Group 1)
Number of subjects: 100
Study: 4078074

Group type: EXPERIMENTAL
Intervention: Ultraviolet B phototherapy with short-contact anthralin
Number of subjects: 11

Group type: COMPARATOR
Intervention: Ultraviolet B phototherapy without short-contact anthralin
Number of subjects: 11
Study: 31466334

Group type: EXPERIMENTAL
Intervention: Glucosylceramide extracted from pineapple (GCP)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 16
Study: 29736633

Group type: EXPERIMENTAL
Intervention: Mother-child-disease triangle (MCDT) intervention, 10 sessions of 90 minutes each over 7 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group received ten simple conversational sessions as a dummy intervention
Number of subjects: 22
Study: 26484869

Group type: COMPARATOR
Intervention: Cognitive Behavioral Treatment (CBT)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Treatment plus Contingency Management (CBT + CM)
Number of subjects: 92
Study: 24397308

Group type: EXPERIMENTAL
Intervention: ECS scheduled at 38(+3) weeks
Number of subjects: 1196

Group type: COMPARATOR
Intervention: ECS scheduled at 39(+3) weeks
Number of subjects: 1196
Study: 23177293

Group type: EXPERIMENTAL
Intervention: 6-min walk test (6MWD)
Number of subjects: 2054

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise test (CPX) - peak oxygen consumption (VO(2))
Number of subjects: 2054

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise test (CPX) - ventilatory equivalents for exhaled carbon dioxide (VE/VCO(2) slope)
Number of subjects: 2054
Study: 20713145

Group type: EXPERIMENTAL
Intervention: Tokishakuyakusan with medicinal cultivar of Paeonia lactiflora (MTS)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tokishakuyakusan with ornamental cultivar of Paeonia lactiflora (OTS)
Number of subjects: 12
Study: 18840266

Group type: EXPERIMENTAL
Intervention: Invited participants (n = 116)
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Diagnosed with diabetes (n = 6)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Non-attenders
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Attenders
Number of subjects: 355
Study: 16101874

Group type: EXPERIMENTAL
Intervention: Kukui nut oil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mineral oil (placebo)
Number of subjects: 30
Study: 12572358

Group type: EXPERIMENTAL
Intervention: 300 mg Ca supplementation per day
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group (no calcium supplementation)
Number of subjects: 161
Study: 10816273

Group type: EXPERIMENTAL
Intervention: Electromechanical mapping of regional left ventricular function
Number of subjects: 10